Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature.
Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature.
复制标题
DOI：
10.1186/s13643-020-01499-z
复制
发表时间：
2020-10-24
影响因子：
3.7
通讯作者：
Hutton B
中科院分区：
文献类型：
--
作者：
Hamel C;Corace K;Hersi M;Rice D;Willows M;Macpherson P;Sproule B;Flores-Aranda J;Garber G;Esmaeilisaraji L;Skidmore B;Porath A;Ortiz Nunez R;Hutton B
甲基苯丙胺的使用和危害正在迅速上升。甲基苯丙胺使用障碍（MUD）和问题甲基苯丙胺使用（PMU）患者的管理是具有挑战性的，没有明确确定的最佳方法;已描述了心理和药理干预。此外，考虑到使用甲基苯丙胺的个体的多样性，有必要评估针对以下亚组的治疗证据：青年;同性恋、双性恋和其他男男性行为者;患有精神健康合并症的个体;以及接受矫正服务的个体。从该领域最近的临床实践指南（CPG）中建立对治疗信息的认识也是有价值的。第一个研究目标是更好地理解MUD和PMU的心理社会和药物治疗对照研究的方法、人群和结果。对这些信息的调查可以帮助建立先进的证据综合（如网络荟萃分析）的潜力，以比较这种疾病的治疗方法，并确定与需要更多初步研究的关键人群相关的差距。总结近期CPG和系统综述中关于MUD/PMU治疗的建议将是一个重要的次要目的。将进行范围审查。使用奥维德平台，检索MEDLINE、Embase、PsycINFO和EBM Reviews的相关科克伦数据库（从数据库开始）。合格标准将包括被描述为患有MUD或PMU的个体，关注的设计包括随机试验、非随机试验和随访3个月或更长时间的对照队列研究;还将寻求系统性综述和CPG。两名评审员（在自动化工具的支持下）将独立筛选所有引文、全文文章和图表数据。对于每种类型的研究设计，将采用不同的方法处理和总结数据。将使用表格和图形绘制证据来源图，并确定证据缺口。这项研究将提高对MUD/PMU总体和亚群中心理社会和药理学干预效果的证据的认识，无论是在最近的CPG/综述还是主要研究方面;对后者的检查也将有助于建立未来综合比较治疗的可行性，如网络荟萃分析。开放科学框架（https：//osf.io/9wy8p）
Methamphetamine use and harms are rising rapidly. Management of patients with methamphetamine use disorder (MUD) and problematic methamphetamine use (PMU) is challenging, with no clearly established best approach; both psychosocial and pharmacologic interventions have been described. Furthermore, given the diversity of individuals that use methamphetamines, there is a need to assess evidence for treatments for subgroups including youths; gay, bisexual, and other men who have sex with men; individuals with mental health comorbidities; and individuals in correction services. Establishing awareness of the messages regarding treatment from recent clinical practice guidelines (CPG) in the field is also of value. The first study objective will be to establish a greater understanding of the methods, populations, and findings of controlled studies for psychosocial and pharmacologic treatments for MUD and PMU. Investigation of this information can help establish the potential for advanced syntheses of the evidence (such as network meta-analysis) to compare therapies for this condition and to identify gaps related to key populations where more primary research is needed. Summarizing the recommendations regarding treatment of MUD/PMU from recent CPGs and systematic reviews will be an important secondary objective. A scoping review will be performed. Using the OVID platform, MEDLINE, Embase, PsycINFO, and relevant Cochrane databases from EBM Reviews will be searched (from databases’ inception onwards). Eligibility criteria will include individuals described as having MUD or PMU, with designs of interest including randomized trials, non-randomized trials, and controlled cohort studies with three or more months of follow-up; systematic reviews and CPGs will also be sought. Two reviewers (with support from automation tools) will independently screen all citations, full-text articles, and chart data. Different approaches to handling and summarizing the data will be implemented for each type of study design. Tables and graphics will be used to map evidence sources and identify evidence gaps. This research will enhance awareness of evidence addressing the effects of psychosocial and pharmacologic interventions for MUD/PMU overall and in sub-populations, both in terms of recent CPGs/reviews and primary studies; inspection of the latter will also help establish the feasibility of future syntheses to compare treatments, such as network meta-analysis. Open Science Framework (https://osf.io/9wy8p)
登录
查看更多内容
影响因子：
2.5
作者：
Cartier, J;Farabee, D;Prendergast, ML
通讯作者：
Prendergast, ML
心理刺激物对苯丙胺和甲基苯丙胺使用障碍的功效和安全性：系统评价和荟萃分析。
影响因子：
3.7
作者：
Bhatt M;Zielinski L;Baker-Beal L;Bhatnagar N;Mouravska N;Laplante P;Worster A;Thabane L;Samaan Z
通讯作者：
Samaan Z
影响因子：
4.4
作者：
Bramness JG;Gundersen ØH;Guterstam J;Rognli EB;Konstenius M;Løberg EM;Medhus S;Tanum L;Franck J
通讯作者：
Franck J
影响因子：
4.3
作者：
Buck JM;Siegel JA
通讯作者：
Siegel JA
影响因子：
1.7
作者：
Brecht ML;Herbeck D
通讯作者：
Herbeck D